Skip to content
Home/Companies/HealthTech/Tempus AI

Tempus AI

HealthTech·United States·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Tempus AI?

Tempus AI is an American HealthTech company, currently owned by Novo Holdings since 2026.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Principal Investments · 1999 · Buyout

Key facts

HQUnited States
SectorHealthTech
StatusActive

More from Novo Holdings Principal Investments

Other portfolio companies in the same fund.

Benchmark Genetics
Active
AgTechUK· 2025
KalVista Pharmaceuticals
Active
PharmaUS· 2025
Schott Poonawalla
Active
IndustrialsIndia· 2025
Catalent
Active
PharmaUS· 2024
Inozyme Pharma
Exited 2025
BiotechUS· 2023
to BioMarin Pharmaceutical
Manipal Hospitals
Active
HealthcareIndia· 2023

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Tempus AI?

Tempus AI is currently owned by Novo Holdings, through Novo Holdings Principal Investments, since 2026.

When did Novo Holdings acquire Tempus AI?

Novo Holdings acquired Tempus AI in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue